Literature DB >> 15479501

Dried blood spots are an acceptable and useful HIV surveillance tool in a remote developing world setting.

S S Solomon1, S Pulimi, I I Rodriguez, S K Chaguturu, S K Satish Kumar, K H Mayer, S Solomon.   

Abstract

Enzyme-linked immunosorbent assay and Western blot analysis of dried blood spots (DBS) on filter paper have been shown to be as sensitive and specific as analysis of serum, and therefore may be a cost-effective and culturally appropriate HIV seroprevalence tool in remote areas. This study examines the acceptability of DBS in a tropical, rural population from an outpatient clinic in Andhra Pradesh, India, where participation was offered to every fifth patient seeking general medical care between March and April 2001. All 1413 patients approached for the study agreed to participate and provide a DBS for examination. The overall HIV seroprevalence in this sample was 2.8%. Of the participants, 51.7% were male, 93.2% were between the ages of 18 and 40, 85.3% were married, 29.7% were employed, 47.6% had no education and 73.1% resided in a rural setting. In the univariate analysis, history of genital warts (P = 0.01), sexually transmitted disease (P = 0.001), premarital sexual intercourse (P = 0.002), sexual contact with a commercial sex worker (P = 0.003), being employed (P = 0.011) and having more than 10 injections for medical purposes (P = 0.006) all correlated with being HIV-infected. Given the uniform willingness of these clinic attendees to be tested, we conclude that DBS is a useful, cost-effective tool in HIV serosurveillance in a rural, tropical setting.

Entities:  

Mesh:

Year:  2004        PMID: 15479501     DOI: 10.1177/095646240401501005

Source DB:  PubMed          Journal:  Int J STD AIDS        ISSN: 0956-4624            Impact factor:   1.359


  10 in total

1.  Distribution of HIV-1 and HSV-2 epidemics in Chad revealing HSV-2 hot-spot in regions of high-risk HIV spread.

Authors:  Charlotte Charpentier; Donato Koyalta; Montana Ndinaromtan; Bagamla Tchobkréo; Mohammad-Ali Jenabian; Nesrine Day; Ali Si-Mohamed; Helen Weiss; Laurent Bélec
Journal:  J Infect Dev Ctries       Date:  2011-02-01       Impact factor: 0.968

2.  Evaluation of dried blood spots for human immunodeficiency virus type 1 drug resistance testing.

Authors:  Amanda McNulty; Cheryl Jennings; Diane Bennett; Joseph Fitzgibbon; James W Bremer; Michael Ussery; Marcia L Kalish; Walid Heneine; J Gerardo García-Lerma
Journal:  J Clin Microbiol       Date:  2006-12-13       Impact factor: 5.948

3.  Stability of Human Immunodeficiency Virus Serological Markers in Samples Collected as HemaSpot and Whatman 903 Dried Blood Spots.

Authors:  Mark M Manak; Holly R Hack; Ashley L Shutt; Brook A Danboise; Linda L Jagodzinski; Sheila A Peel
Journal:  J Clin Microbiol       Date:  2018-09-25       Impact factor: 5.948

4.  Evaluation of different RNA extraction methods and storage conditions of dried plasma or blood spots for human immunodeficiency virus type 1 RNA quantification and PCR amplification for drug resistance testing.

Authors:  Marjorie Monleau; Céline Montavon; Christian Laurent; Michel Segondy; Brigitte Montes; Eric Delaporte; François Boillot; Martine Peeters
Journal:  J Clin Microbiol       Date:  2009-02-04       Impact factor: 5.948

5.  No significant HTLV seroprevalence in German people who inject drugs.

Authors:  Oliver Hohn; Stephen Norley; Claudia Kücherer; Ali Bazarbachi; Hiba El Hajj; Ulrich Marcus; Ruth Zimmermann; Norbert Bannert
Journal:  PLoS One       Date:  2017-08-22       Impact factor: 3.240

6.  Dried blood spots as a source of anti-malarial antibodies for epidemiological studies.

Authors:  Patrick H Corran; Jackie Cook; Caroline Lynch; Heleen Leendertse; Alphaxard Manjurano; Jamie Griffin; Jonathan Cox; Tarekegn Abeku; Teun Bousema; Azra C Ghani; Chris Drakeley; Eleanor Riley
Journal:  Malar J       Date:  2008-09-30       Impact factor: 2.979

7.  HIV-1 drug resistance genotyping from dried blood spots stored for 1 year at 4 degrees C.

Authors:  Ae S Youngpairoj; Silvina Masciotra; Carolina Garrido; Natalia Zahonero; Carmen de Mendoza; J Gerardo García-Lerma
Journal:  J Antimicrob Chemother       Date:  2008-03-15       Impact factor: 5.790

8.  HIV prevention in favour of the choice-disabled in southern Africa: study protocol for a randomised controlled trial.

Authors:  Neil Andersson; Anne Cockcroft; Lehana Thabane; Nobantu Marokoane; Ditiro Laetsang; Mokgweetsi Masisi
Journal:  Trials       Date:  2013-08-29       Impact factor: 2.279

9.  Evolution of the global burden of viral infections from unsafe medical injections, 2000-2010.

Authors:  Jacques Pépin; Claire Nour Abou Chakra; Eric Pépin; Vincent Nault; Louis Valiquette
Journal:  PLoS One       Date:  2014-06-09       Impact factor: 3.240

10.  Dried blood spot testing for the antenatal screening of HTLV, HIV, syphilis, toxoplasmosis and hepatitis B and C: prevalence, accuracy and operational aspects.

Authors:  Ney Boa-Sorte; Antônio Purificação; Tatiana Amorim; Lorena Assunção; Alan Reis; Bernardo Galvão-Castro
Journal:  Braz J Infect Dis       Date:  2014-07-09       Impact factor: 3.257

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.